ProfileGDS4718 / 244428_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 54% 50% 83% 53% 54% 53% 51% 55% 51% 50% 54% 52% 53% 46% 52% 52% 50% 50% 52% 53% 52% 53% 50% 50% 51% 50% 54% 51% 49% 51% 50% 57% 50% 47% 53% 51% 49% 54% 57% 84% 53% 54% 54% 53% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.7815354
GSM549102patient 115, normal, homogenized [OPG study]5.5640850
GSM549104patient 119, normal, homogenized [OPG study]8.2328183
GSM549108patient 138, normal, homogenized [OPG study]5.7501253
GSM549119patient 077, normal, homogenized [OPG study]5.7821754
GSM549133patient 032, cancer, homogenized [OPG study]5.6256853
GSM549139patient 042, cancer, homogenized [OPG study]5.5501451
GSM549099patient 107, normal, homogenized [OPG study]5.7818955
GSM549109patient 139, normal, homogenized [OPG study]5.6014951
GSM549110patient 046, normal, homogenized [OPG study]5.5340650
GSM549114patient 063, normal, homogenized [OPG study]5.7059854
GSM549122patient 082, normal, homogenized [OPG study]5.631152
GSM549134patient 033, cancer, homogenized [OPG study]5.6688853
GSM549136patient 036, cancer, homogenized [OPG study]5.247146
GSM549140patient 044, cancer, homogenized [OPG study]5.615452
GSM549111patient 047, normal, homogenized [OPG study]5.6221152
GSM549113patient 057, normal, homogenized [OPG study]5.4797150
GSM549132patient 031, cancer, homogenized [OPG study]5.4750150
GSM549137patient 038, cancer, homogenized [OPG study]5.6325852
GSM549142patient 047, cancer, homogenized [OPG study]5.7883353
GSM549100patient 110, normal, homogenized [OPG study]5.6395652
GSM549107patient 135, normal, homogenized [OPG study]5.6447953
GSM549115patient 068, normal, homogenized [OPG study]5.4836650
GSM549116patient 072, normal, homogenized [OPG study]5.4846850
GSM549120patient 078, normal, homogenized [OPG study]5.5892151
GSM549131patient 030, cancer, homogenized [OPG study]5.4836650
GSM549118patient 074, normal, homogenized [OPG study]5.7210554
GSM549129patient 027, cancer, homogenized [OPG study]5.6042651
GSM549123patient 088, normal, homogenized [OPG study]5.4173849
GSM549124patient 006, cancer, homogenized [OPG study]5.5716651
GSM549126patient 015, cancer, homogenized [OPG study]5.5027850
GSM549128patient 025, cancer, homogenized [OPG study]5.9512657
GSM549103patient 117, normal, homogenized [OPG study]5.5752650
GSM549117patient 073, normal, homogenized [OPG study]5.3042647
GSM549138patient 041, cancer, homogenized [OPG study]5.700153
GSM549141patient 045, cancer, homogenized [OPG study]5.531751
GSM549130patient 028, cancer, homogenized [OPG study]5.4800949
GSM549101patient 111, normal, homogenized [OPG study]5.7841454
GSM549105patient 128, normal, homogenized [OPG study]5.9290757
GSM549106patient 134, normal, homogenized [OPG study]8.4973284
GSM549112patient 048, normal, homogenized [OPG study]5.7065453
GSM549125patient 011, cancer, homogenized [OPG study]5.7800454
GSM549127patient 024, cancer, homogenized [OPG study]5.7639554
GSM549135patient 035, cancer, homogenized [OPG study]5.6686253